Sacubitril/Valsartan(LCZ696)：A Blockbuster in Heart Failure
Sacubitril/Valsartan(LCZ696)is a fixed dose combination acts as an anti-hypertensive and cardiovascular agent. It is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction[1][2]. It is a blockbuster with approximately $ 7,000 million in sales forecast in the year 2025.
ChemExpresscan provide Sacubitril/Valsartan(LCZ696) API and intermediates. We have mature technology, stable supply and production capacity of tons.please contact us at (+86) 021-58950125 or send email to [email protected].
Reference：
[1] Cardiol Rev. 2016Jan-Feb;24(1):41-7.
[2] In: StatPearls.2023Jan–. PMID: 29939681.
About ChemExpress
● We focus on providing RSMs, intermediates, APIs/HPAPIs, especially with high difficulty and high-performance process development, scale-up, and registration
● Products of raw materials and intermediate (100kg to tons) required for preclinical/clinical stage and commercialization
● Anti-tumor, anti-virus, diabetes, cardio cerebral Vascular disease treatment and other fields
● 120+ types of raw materials and intermediate products, of which 100+ products are commercialized
● Special Reactions: Grignard reaction, Oxidation reaction, Chlorination reaction, Hydrogenation reaction, High-pressure hydrogenation, Ultralow temperature reaction, Diazotization reaction, Nitration reaction, Chlorination reaction
If you want to know more about our products and capabilities, please click the website of ChemExpress:
https://www.chemexpress.com/category/intermediate-for-api-production-1